Rxivist logo

SIRT2 and lysine fatty acylation regulate the oncogenic activity of K-Ras4a

By Hui Jing, Xiaoyu Zhang, Stephanie A. Wisner, Xiao Chen, Nicole A. Spiegelman, Maurine E. Linder, Hening Lin

Posted 15 Oct 2017
bioRxiv DOI: 10.1101/203638 (published DOI: 10.7554/elife.32436)

Ras proteins play vital roles in numerous biological processes and Ras mutations are found in many human tumors. Understanding how Ras proteins are regulated is important for elucidating cell signaling pathways and identifying new targets for treating human diseases. Here we report that one of the K-Ras splice variants, K-Ras4a, is subject to lysine fatty acylation, a previously under-studied protein post-translational modification. Sirtuin 2 (SIRT2), one of the mammalian nicotinamide adenine dinucleotide (NAD)-dependent lysine deacylases, catalyzes the removal of fatty acylation from K-Ras4a. We further demonstrate that SIRT2-mediated lysine defatty-acylation promotes endomembrane localization of K-Ras4a, enhances its interaction with A-Raf, and thus promotes cellular transformation. Our study identifies lysine fatty acylation as a previously unknown regulatory mechanism for the Ras family of GTPases that is distinct from cysteine fatty acylation. These findings highlight the biological significance of lysine fatty acylation and sirtuin-catalyzed protein lysine defatty-acylation.

Download data

  • Downloaded 345 times
  • Download rankings, all-time:
    • Site-wide: 72,283
    • In biochemistry: 1,988
  • Year to date:
    • Site-wide: 77,513
  • Since beginning of last month:
    • Site-wide: 78,030

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)